Table 1 Baseline characteristics of the patients
|  | I group(n = 60) | NI group(n = 20) | P -value |
|---|---|---|---|
Clinical data | Â | Â | Â |
Age (years) | 59(50,66) | 67(57,75) | 0.013 |
Male n(%) | 42(70.0) | 12(60.0) | 0.408 |
Height (cm) | 168.9 ± 8.6 | 165.1 ± 9.9 | 0.103 |
Weight (kg) | 74.7 ± 13.0 | 70.0 ± 14.3 | 0.136 |
BMI (kg/m2) | 26.07 ± 3.29 | 25.28 ± 3.26 | 0.353 |
AF duration (months) | 3.0(1.0,24.0) | 4.0(1.0,24.0) | 0.505 |
Past history | Â | Â | Â |
Hypertension n(%) | 24(40.0) | 8(40.0) | 1 |
Diabetes n(%) | 10(16.7) | 2(10.0) | 0.718 |
CHD n(%) | 16(26.7) | 5(25.0) | 0.883 |
Previous stroke n(%) | 11(18.3) | 5(25.0) | 0.747 |
Smoker n(%) | 12(20.0) | 3(15.0) | 0.869 |
Drinker n(%) | 13(21.7) | 4(20.0) | 1 |
Medication | Â | Â | Â |
ACEI/ARB/ARNI n(%) | 46(76.7) | 15(75.0) | 0.879 |
\(\beta\)-block n(%) | 53(88.3) | 16(80.0) | 0.574 |
Diuretic n(%) | 44(73.3) | 13(65.0) | 0.476 |
SGLT-2i n(%) | 10(16.7) | 2(10.0) | 0.718 |
Digoxin n(%) | 12(20.0) | 3(15.0) | 0.869 |